Radiology Information System Market Likely to Reach a Valuation of around USD 980.2 Million by 2024: Grand view Research, Inc.

The global Radiology Information System Market is expected to reach USD 980.2 million by 2024, according to a new report by Grand View Research, Inc. Rising demand for information technology solutions to streamline workflow in radiology units is contributing to the growth of RIS market. RIS allows radiologists and medical imaging professionals to keep a track of patient history and digital data generated during diagnosis and treatment procedures.

Computerized medical imaging provides interactive documents that are secured and convenient. These documents can be accessed across various healthcare departments. RIS provides a communication link between primary physicians and imaging departments for better care coordination, which can be beneficial for timely diagnosis or treatments to the patients.

The healthcare providers using certified RIS software are eligible to receive financial incentives. The care providers need to demonstrate stage 2 meaningful use of RIS software. Eligible professionals receive upwards of USD 63,750 from Medicaid and upwards of USD 44,000 from Medicare. This government initiative is a major contributor to the increased adoption of RIS software by the radiologists and medical imaging professionals.

Full Research Report On radiology information system market Analysis:
https://www.grandviewresearch.com/industry-analysis/radiology-information-system-ris-market

Further Key Findings From The Report Suggest:

·         The rapid growth in chronic diseases along with rising geriatric population base is accountable for RIS market growth.

·         The available types of radiology information solutions include integrated and standalone systems. Of these, the integrated RIS accounted for majority of the segment share in the year 2015.

·         Integrated RIS offers data analysis with the help of picture archiving and communication system (PACS) for development of IT service models

·         The RIS deployment modes include web-based systems, cloud-based systems, and on premise systems. Of these, web-based systems held majority of the market share in 2015, due to offered workflow enhancement features such as scheduling, document imaging, automated insurance eligibility functions and billing.

·         Hospitals, emergency healthcare service providers, and physicians comprise of RIS end-users. Hospitals majorly prefer radiology solutions for patient scheduling, appointments, and for tracking patient history and records.

·         North America dominated the market in 2015 in terms of revenue share pertaining to the technological advancements and presence of major market players in the region.

·         The American College of Radiology has collaborated with GE Healthcare to bring the first leading boot camp training for breast cancer in Saudi Arabia and the Middle East to enter and expand in the region.

·         GE Healthcare, Siemens AG, Cerner Corporation, Allscripts Healthcare Solutions, Inc., Epic Systems, McKesson Corporation, Philips Healthcare, Merge Healthcare, Inc., and MedInformatix, Inc. are some of the key players operating in this market.

View More Reports Of This Category By Grand View Research At: https://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the radiology information system market based on product, deployment mode, end-use, and region:

Product Outlook (Revenue, USD Million; 2014 - 2024)

·         Integrated

·         Standalone

Deployment Mode Outlook (Revenue, USD Million; 2014 - 2024)

·         Cloud-based

·         Web-based

·         On-premise

End-Use Outlook (Revenue, USD Million; 2014 - 2024)

·         Hospitals

·         Outpatient Department (OPD) Clinics

·         Others

Regional Outlook (Revenue, USD Million; 2014 - 2024)

·         North America

o    U.S.

o    Canada

·         Europe

o     UK

o    Germany

·         Asia Pacific

o    Japan

o    China

·         Latin America

o    Brazil

o    Mexico

·         Middle East & Africa

o    SouthAfrica

View Press Release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-radiology-information-system-ris-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Epigenetics Market Likely to Reach a Valuation of around USD 16.31 Billion by 2022: Grand view Research, Inc.

The global Epigenetics Market is expected to reach USD 16.31 billion by 2022, according to a new report by Grand View Research, Inc. Growing worldwide prevalence of cancer and other diseases with epigenetic modification base is expected to drive market growth during the forecast period. 

Diagnostic companies are coming up with new products such as antibodies specific for the detection of modifications and new upgraded kits for easy and efficient detection of biomarkers. This is expected to attract pharmaceutical companies to collaborate for the development of therapeutic drugs. 

Presence of pipeline drugs and their expected commercialization is anticipated to boost penetration rates over the forecast period. For instance, Ramucirumab (Cyramza) by Eli Lilly and Company was approved by the FDA for use in combination with Folfiri for the treatment of patients with metastatic colorectal cancer. 

Technology advancements in the field of epigenetics especially pertaining to the detection of methylation markers related to cancer development is expected to improve usage rates during the forecast period. For instance, Epi proLung BL Reflex Assay by Epigenomics helps in the diagnosis of lung cancer by determining methylation of SHOX2 biomarker gene. 

Full Research Report On epigenetics market Analysis:
http://www.grandviewresearch.com/industry-analysis/epigenetics-market

Further key findings from the report suggest:

·         Epigenetic reagents was the largest market valued at over USD 1.2 billion in 2014 owing to the increasing amount of R&D investments and high consumption rates. Kits are expected to gain rapid growth in demand due to the increasing need of rapid and accurate detection techniques.

·         DNA methylation was the largest technology segment accounting for over 47.0% revenue in 2014. The introduction of technological advancement such as Methylation Sensitive PCR (MSP) and rapid adoption of these products to improve diagnostics efficiency are some factors attributing for its largest share.

·         Oncology was the largest application market, with revenue valued at over USD 2.75 billion. Growing prevalence of cancer with epigenetic modification base and strong product pipeline are some factors attributing to its market position.

·         Non oncology segment is anticipated to register the fastest growth of over 20.0% during the forecast period. The segment is dominated by metabolic diseases owing to, the growing base of population suffering from diabetes and organ failure and increasing prevalence of sedentary lifestyle.

·         North America was observed to be the largest regional epigenetics market accounting for over 38.0% of the overall revenue, due to factors such as the increasing cancer prevalence, increasing amount of funding for R&D, growing collaborations between large pharmaceutical firms for development of improved therapeutics, high patient awareness levels.

·         The Asia Pacific market is estimated to witness lucrative growth over the forecast period owing to, the presence of large prevalence of target diseases and high unmet medical needs

·         Some key players of the epigenetics market include Illumina, Abcam, Diagenode, Thermo Fisher Scientific, Merck, Zymo research, Qiagen, CellCentric Ltd, Chroma Therapeutics Ltd, Eisai Co. Ltd, Novartis International AG, Oncolys Biopharma Inc., Syndax Pharmaceuticals, Inc., Valirx Plc and Sigma-Aldrich Corporation.

·         Extensive R&D initiatives aimed at the development of novel drugs and the presence of strong product pipeline is expected to further boost market growth over the forecast period. 

View More Reports Of This Category By Grand View Research At: https://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global epigenetics market on the basis of product, technology, application and region:

Epigenetics Product Outlook (Revenue, USD Million, 2015 - 2022)

·         Reagents

·         Kits

·         Instruments

·         Enzymes

·         Services

Epigenetics Technology Outlook (Revenue, USD Million, 2015 - 2022)

·         DNA Methylation

·         Histone Methylation

·         Histone Acetylation

·         Large noncoding RNA

·         MicroRNA Modification

·         Chromatin structures

Epigenetics Application Outlook (Revenue, USD Million, 2015 - 2022)

·         Oncology

o    Solid Tumors

o    Liquid Tumors

·         Non Oncology

o    Inflammatory Diseases

o    Metabolic Diseases

o    Infectious Diseases

o    Cardiovascular Diseases

Epigenetics Market  Regional Outlook(Revenue, USD Million, 2015 - 2022)

o    North America

o    U.S.

o    Canada

o    Europe

o    UK

o    Germany

o    Asia Pacific

o    Japan

o    China

o    India

o    Latin America

o    Brazil

o    Mexico

o    Middle East and Africa (MEA)

o    South Africa

Access Full Press Release of this Report:
https://www.grandviewresearch.com/press-release/global-eclinical-solutions-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: https://www.grandviewresearch.com/

EClinical solutions market Likely To Reach A Valuation Of Around USD 12.05 Million by 2025: Grand view Research, Inc.

The global eClinical solutions market size is expected to reach USD 12.05 million by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 13.6% during the forecast period. Increasing research and development activities by biopharma and pharma companies, rising application of software solutions in clinical trials, and expanding customer base are anticipated to fuel the demand for eClinical solutions.

The eClinical solutions market is estimated to witness phenomenal growth over the forecast period. Technological advancements in the field of clinical trials such as electronic data capture and prevalence of Wi-Fi connectivity are projected to drive the market in coming years. As the demand for tracking and analyzing clinical data increases, the need for effective clinical solutions rises. Unmet needs to manage efficient clinical development process are poised to boost the growth of the market over the forecast period.

Moreover, digital transformation in the field of clinical trials and shifting preference towards data centric approach are providing a tremendous push to the market. Demand for integrated clinical IT solutions is increasing due to massive volume of data generated during clinical development processes. eClinical solutions offer single source of information that helps in optimizing the cost by eliminating redundant data entry and reducing on-site verification and source data verification rate. Rising awareness regarding these benefits is propelling the market.

Adoption of eClinical workflows in trials offer enormous potential in clinical development processes. These solutions can facilitate decision making in each stage of development. It also helps in reducing cost & time between development phase by utilizing seamless designs & identifying failing compounds. In addition, it offers rapid access to data & patient safety information, which is helpful in making quick decisions.

Full research report on eClinical solutions market analysis: https://www.grandviewresearch.com/industry-analysis/eclinical-solutions-market

 Further Key Findings From the Study Suggest:

• CTMS dominated the product segment in 2016 owing to associated benefits such as centralized end-to-end management of clinical trial activities, elimination of reliance on manual processes, real-time status tracking, and maintenance of multiple databases, which cumulatively improve the overall efficiency of clinical trials
• On-premise eClinical solutions are most commonly preferred solutions. The preference for these services is mainly due to complete access to information and have full control within the premise
• Key market players are engaged in various strategies such as mergers & acquisitions and new product development to gain market penetration
• New product development and strategic alliances including partnership agreements, promotional activities, and acquisitions are instrumental in keeping market rivalry high
• For instance, in February 2016, Oracle Health Sciences entered into an agreement with Bayer Healthcare to provide its clinical e-monitoring solutions, Oracle Siebel Clinical Trial Management System, to the latter

View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the global eClinical solutions market report on the basis of end-user application and region:

eClinical Solutions Product Outlook (Revenue, USD Million, 2014 - 2025)

• Electronic Clinical Outcome Assessment (eCOA)
• Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS) 
• Clinical Analytics Platforms
• Clinical Data Integration Platforms
• Safety Solutions
• Clinical Trial Management Systems (CTMS)
• Randomization and Trial Supply Management (RTSM) 
• Electronic Trial Master File (eTMF)

eClinical Solutions Delivery Mode Outlook (Revenue, USD Million, 2014 - 2025)

• Web-hosted (On-demand)
• Licensed Enterprise (On-premise)
• Cloud-based

eClinical Solutions Clinical Trial Outlook (Revenue, USD Million, 2014 - 2025)

• Phase I
• Phase II
• Phase III
• Phase IV

eClinical Solutions End-use Outlook (Revenue, USD Million, 2014 - 2025)

• Hospitals
• CROs
• Academic Institutes
• Pharmaceutical Biopharmaceutical Companies
• Medical Device Manufactures

eClinical Solutions, Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• S.
• Canada
• Mexico
• Europe
• K.
• Germany
• France
• Italy
• Spain
• Netherlands
• Sweden
• Denmark
• Asia Pacific
• Japan
• China
• India
• Korea
• Australia
• New Zealand
• Taiwan
• Hong Kong
• Singapore
• Thailand
• Vietnam
• Latin America
• Brazil
• Argentina
• Chile
• Middle East & Africa
• South Africa
• Saudi Arabia
• A.E
• Egypt
• Qatar 

Access Full Press Release of this Report:
https://www.grandviewresearch.com/press-release/global-eclinical-solutions-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: https://www.grandviewresearch.com/